SL-01
SL-01 is an orally bioavailable gemcitabine derivative that demonstrates enhanced potency in suppressing human breast cancer growth by inducing apoptosis. It is a valuable research tool for investigating novel chemotherapeutic strategies in both in vitro and in vivo oncology models.
Product Specifications
CAS Number
26049-94-5
Product Name Alternative
ZPCK
Field of Research
Cell Biology, Molecular Biology
Purity
> 98%
Bioactivity
P53/mdm2 inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 15 mg/ml with warming) .
Smiles
ClCC (=O) [C@H] (Cc1ccccc1) NC (=O) OCc1ccccc1
Molecular Formula
C18H18ClNO3
Molecular Weight
331.8
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N-Benzyloxycarbonyl-L-phenylalaninylchloromethyl ketone
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog